![](https://cdn.myportfolio.com/77d130b254bfd78b05a2d2c1a7492c9d/cf4c3cb3-43e0-4954-bdcd-45ea247cc789_rw_1920.jpg?h=da8bd5aa23b44ca60387bf9aaa2ff347)
Drug Development Pitch Deck: ClearSight
ClearSight Therapeutics (CSTx) was founded to develop biotech products and therapies to treat common ocular conditions.
CSTx proprietary compounds treat microbial infections in a fundamentally different way than other antibiotics by stimulating innate immune response. ClearSight's novel anti-microbial aims to address multiple segments in the ophthalmic space.
I had the chance to help create ClearSight Therapeutics' pitch deck and one-pager for raising seed capital to fund drug development.
![](https://cdn.myportfolio.com/77d130b254bfd78b05a2d2c1a7492c9d/b59b6408-f3c3-4586-9cf8-afaad135f7fc_rw_1920.jpg?h=8b6c64cb1b2faff693aba74e742e3b0d)
![](https://cdn.myportfolio.com/77d130b254bfd78b05a2d2c1a7492c9d/9024438b-adcb-4004-b914-4f5f52966c2a_rw_1920.jpg?h=f7bf58ed41ac248f96bc44621f7383fe)
![](https://cdn.myportfolio.com/77d130b254bfd78b05a2d2c1a7492c9d/62173489-a9a5-461c-8d0c-13423c05ef0e_rw_1920.jpg?h=359dbfec2b82f685f9a41c9a001cdb09)
Like this design? Create your own showcase like this!
Download the templates below that were featured in this portfolio page!
↓ ↓ ↓
Download the templates below that were featured in this portfolio page!
↓ ↓ ↓
![](https://cdn.myportfolio.com/77d130b254bfd78b05a2d2c1a7492c9d/1e4f918b-129f-49b1-b135-dc11951b90d8_rw_1920.jpg?h=4967782049106fced6a215d15b8e3f63)
Verified Customer Review of Vip Sitaraman:
"I had the pleasure of working with Vip on the development of top-class Seed Funding materials for my Biotech Start-up. He did a fantastic job of bringing our story to life in a concise and compelling way! He was easy to work with and the turn-around of materials was very efficient. I would strongly recommend him to any company founders or executives looking to communicate their business plan or proposal in an impactful way! Thank you Vip!"
–
Patrick Smale
CEO & Founder, ClearSight Therapeutics
CEO & Founder, ClearSight Therapeutics